Multiple myeloma affects the several parts of bodies such as the spine, skull,pelvis and ribs. The cause of multiple myeloma is not known properly. The poor prognoses is associated with most cancers creates a sense of urgency for the brains behind healthcare Artificial Intelligence (AI) research. AI is able to detect cancer and other diseases earlier than possible through standard diagnostic methods, which could be lifesaving for future patients. The main objective of the research paper is to predict the Albumin to Globulin (A/G) ratio obtained by the electrophoresis test by developing regression model and Artificial Neural Network (ANN) model. The results obtained showed that the Mean Square Error (MSE) obtained by ANN model is less than t...
The search for markers that are able to predict the conversion of amnestic mild cognitive impairment...
Thesis (Ph.D.)--University of Washington, 2012During the course of care, patients frequently develop...
The development of a new protein drug typically starts with the design, expression and biophysical c...
International audienceMultiple myeloma affects the several parts of bodies such as the spine, skull,...
Pathological changes in an organ or tissue may be reflected in proteomic patterns in serum. The earl...
Background: To investigate the potential use of Artificial Neural Network (ANN) in the evaluation of...
Objective. Currently available tumor markers for ovarian cancer are still inadequate in both sensiti...
AbstractBiomedical prediction based on clinical and genome-wide data has become increasingly importa...
It has been indicated that total prostate specific antigen (PSA) screening, one of the serum markers...
High-throughput technologies such as DNA/RNA microarrays, mass spectrometry and protein chips are cr...
Artificial intelligence was recognised many years ago as a potential and powerful tool to predict di...
The health, mortality and morbidity rates of neonatal ruminants depend on colostrum quality and the ...
PURPOSE: New techniques for the prediction of tumor behavior are needed, because statistical analysi...
A cut-off of 5 circulating tumor cells (CTCs) per 7.5 ml of blood in metastatic breast cancer (MBC) ...
The aim of Artificial Intelligence is to develop the machines to perform the tasks in a better way t...
The search for markers that are able to predict the conversion of amnestic mild cognitive impairment...
Thesis (Ph.D.)--University of Washington, 2012During the course of care, patients frequently develop...
The development of a new protein drug typically starts with the design, expression and biophysical c...
International audienceMultiple myeloma affects the several parts of bodies such as the spine, skull,...
Pathological changes in an organ or tissue may be reflected in proteomic patterns in serum. The earl...
Background: To investigate the potential use of Artificial Neural Network (ANN) in the evaluation of...
Objective. Currently available tumor markers for ovarian cancer are still inadequate in both sensiti...
AbstractBiomedical prediction based on clinical and genome-wide data has become increasingly importa...
It has been indicated that total prostate specific antigen (PSA) screening, one of the serum markers...
High-throughput technologies such as DNA/RNA microarrays, mass spectrometry and protein chips are cr...
Artificial intelligence was recognised many years ago as a potential and powerful tool to predict di...
The health, mortality and morbidity rates of neonatal ruminants depend on colostrum quality and the ...
PURPOSE: New techniques for the prediction of tumor behavior are needed, because statistical analysi...
A cut-off of 5 circulating tumor cells (CTCs) per 7.5 ml of blood in metastatic breast cancer (MBC) ...
The aim of Artificial Intelligence is to develop the machines to perform the tasks in a better way t...
The search for markers that are able to predict the conversion of amnestic mild cognitive impairment...
Thesis (Ph.D.)--University of Washington, 2012During the course of care, patients frequently develop...
The development of a new protein drug typically starts with the design, expression and biophysical c...